Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

iBio Inc. (IBIO)

1.96   -0.12 (-5.77%) 07-02 16:00
Open: 1.9 Pre. Close: 2.08
High: 2.06 Low: 1.9
Volume: 8,810,873 Market Cap: 235M
iBio, Inc., a biotechnology company, provides product development and manufacturing services to clients, collaborators, and third-party customers in the United States and internationally. The company's services cover the stages of pre-clinical development, regulatory approval, commercial product launch, and on-going commercial phase requirements. Its lead therapeutic candidate is IBIO-CFB03 for the treatment of systemic scleroderma, idiopathic pulmonary fibrosis, and other fibrotic diseases. The company is also developing vaccine candidates for third parties. It has a license agreement with the University of Natural Resources and Life Sciences, Vienna; a strategic relationship with Beijing CC-Pharming Ltd.; and collaboration agreements with AzarGen Biotechnologies (Pty) Ltd, The Texas A&M University System, and Fraunhofer Center for Molecular Biotechnology. In addition, the company offers a range of product and process development, analytical, and manufacturing services. iBio, Inc.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.054 - 2.067 2.067 - 2.076
Low: 1.892 - 1.907 1.907 - 1.919
Close: 1.939 - 1.963 1.963 - 1.98

Technical analysis

as of: 2020-07-02 4:31:11 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 2.56     One year: 3.15
Support: Support1: 1.38    Support2: 1.15
Resistance: Resistance1: 2.20    Resistance2: 2.70
Pivot: 1.74
Moving Average: MA(5): 2.17     MA(20): 1.68
MA(100): 1.26     MA(250): 0.76
MACD: MACD(12,26): 0.18     Signal(9): 0.13
Stochastic oscillator: %K(14,3): 53.54     %D(3): 62.59
RSI: RSI(14): 58.25
52-week: High: 3.40  Low: 0.05  Change(%): 184.1
Average Vol(K): 3-Month: 1538992  10-Days: 3337186

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
IBIO has closed below upper band by 33.2%. Bollinger Bands are 46.7% wider than normal. The large width of the bands suggest high volatility as compared to IBIO's normal range. The bands have been in this wide range for 2 bars. This is a sign that the current trend might continue.

Headline News

Thu, 02 Jul 2020
Why iBio Is an Excellent Pandemic Spec Play -

Thu, 02 Jul 2020
Buy or Sell iBio, Inc. (IBIO) Stock Now? Don't Try to Be a Top Gun - The News Heater

Wed, 01 Jul 2020
Market Reactions to Ibio Inc (IBIO) Stock Getting a Neutral Rating - InvestorsObserver

Tue, 30 Jun 2020
Is Ibio Inc (IBIO) Stock a Top Performer in the Healthcare Sector? - InvestorsObserver

Tue, 30 Jun 2020
iBio Inc. (AMEX:IBIO) Stock is Soaring, Here is Why - The Oracle Dispatch

Mon, 29 Jun 2020
Is Ibio Inc (IBIO) Stock Near the Top of the Biotechnology Industry? - InvestorsObserver

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE American
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 120
Shares Float (M) 102
% Held by Insiders 8.78
% Held by Institutions 11.56
Shares Short (K) 2,140
Shares Short P. Month (K) 2,840

Stock Financials

EPS -0.975
EPS Est This Year -0.150
EPS Est Next Year -0.200
Book Value (p.s.) 0.040
Profit Margin
Operating Margin -1138.46
Return on Assets (ttm) -24.0
Return on Equity (ttm) -320.6
Qtrly Rev. Growth -81.8
Gross Profit (p.s.) 0.017
Sales Per Share 0.011
EBITDA (p.s.) -0.107
Qtrly Earnings Growth
Operating Cash Flow (M) -14
Levered Free Cash Flow (M) -8

Stock Valuations

PE Ratio -2.01
PEG Ratio
Price to Book value 49.00
Price to Sales 179.24
Price to Cash Flow -16.93

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.